215 Publications (Page 3 of 9)
2014
Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.
Phillips, Gail D Lewis⋅Fields, Carter T⋅Li, Guangmin⋅Dowbenko, Donald⋅Schaefer, Gabriele⋅Miller, Kathy⋅Andre, Fabrice⋅Burris, Howard A⋅Albain, Kathy S⋅Harbeck, Nadia⋅Dieras, Veronique⋅Crivellari, Diana⋅Fang, Liang⋅Guardino, Ellie⋅Olsen, Steven R⋅Crocker, Lisa M and Sliwkowski, Mark X
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 20, (no. 2), pp. 456-468, January 15, 2014. | Journal Article
 
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Schneider, Bryan P⋅Li, L⋅Shen, Fei⋅Miller, Kathy D⋅Radovich, M⋅O'Neill, A⋅Gray, R J⋅Lane, D⋅Flockhart, David A⋅Jiang, G⋅Wang, Z⋅Lai, D⋅Koller, D⋅Pratt, J H⋅Dang, C T⋅Northfelt, D⋅Perez, E A⋅Shenkier, T⋅Cobleigh, M⋅Smith, M L⋅Railey, E⋅Partridge, A⋅Gralow, J⋅Sparano, Joseph A⋅Davidson, Nancy E⋅Foroud, T and Sledge, G W
British journal of cancer, vol. 111, (no. 6), pp. 1241-8, 2014/Sep/9. | Journal Article
 
Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer.
Miller, Kathy D⋅Diéras, Véronique⋅Harbeck, Nadia⋅Andre, Fabrice⋅Mahtani, Reshma L⋅Gianni, Luca⋅Albain, Kathy S⋅Crivellari, Diana⋅Fang, Liang⋅Michelson, Glenn⋅de Haas, Sanne L and Burris, Howard A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 32, (no. 14), pp. 1437-44, 2014/May/10. | Journal Article
 
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
O'Shaughnessy, Joyce⋅Schwartzberg, Lee⋅Danso, Michael A⋅Miller, Kathy D⋅Rugo, Hope S⋅Neubauer, Marcus⋅Robert, Nicholas⋅Hellerstedt, Beth⋅Saleh, Mansoor⋅Richards, Paul⋅Specht, Jennifer M⋅Yardley, Denise A⋅Carlson, Robert W⋅Finn, Richard S⋅Charpentier, Eric⋅Garcia-Ribas, Ignacio and Winer, Eric P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 32, (no. 34), pp. 3840-3847, December 1, 2014. | Journal Article
2013
A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109.
Mina, Lida A⋅Yu, Menggang⋅Johnson, Cynthia⋅Burkhardt, Cyndi⋅Miller, Kathy D and Zon, Robin
Investigational new drugs, vol. 31, (no. 5), pp. 1307-10, 2013/Oct. | Journal Article
 
Biomarker prediction of chemotherapy-related amenorrhea
Ruddy, Kathryn Jean⋅Ruddy, Kathryn Jean⋅O'Neill, Anne M⋅O'Neill, Anne M⋅Miller, Kathy⋅Miller, Kathy⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Baker, Emily⋅Baker, Emily⋅Sparano, Joseph A⋅Sparano, Joseph A⋅Dang, Chau T⋅Dang, Chau T⋅Northfelt, Donald W⋅Northfelt, Donald W⋅Sledge, George W and Sledge, George W
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 9508, 2013-05-20. | Journal Article
 
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Schneider, Bryan P⋅Schneider, Bryan P⋅Gray, Robert J⋅Gray, Robert J⋅Radovich, Milan⋅Radovich, Milan⋅Shen, Fei⋅Shen, Fei⋅Vance, Gail⋅Vance, Gail⋅Li, Lang⋅Li, Lang⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Miller, Kathy D⋅Miller, Kathy D⋅Gralow, Julie R⋅Gralow, Julie R⋅Dickler, Maura N⋅Dickler, Maura N⋅Cobleigh, Melody A⋅Cobleigh, Melody A⋅Perez, Edith A⋅Perez, Edith A⋅Shenkier, Tamara N⋅Shenkier, Tamara N⋅Vang Nielsen, Kirsten⋅Vang Nielsen, Kirsten⋅Müller, Sven⋅Müller, Sven⋅Thor, Ann⋅Thor, Ann⋅Sledge, George W⋅Sledge, Jr, George W⋅Sparano, Joseph A⋅Sparano, Joseph A⋅Davidson, Nancy E⋅Davidson, Nancy E⋅Badve, Sunil S and Badve, Sunil S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 19, (no. 5), pp. 1281-9, 2013/Mar/1. | Journal Article
 
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
Yardley, Denise A⋅Ismail Khan, Roohi⋅Melichar, Bohuslav⋅Lichinitser, Mikhail⋅Munster, Pamela⋅Klein, Pamela M⋅Cruickshank, Scott⋅Miller, Kathy D⋅Lee, Min J and Trepel, Jane
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, (no. 17), pp. 2128-35, 2013/Jun/10. | Journal Article
 
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
Tevaarwerk, Amye J⋅Gray, Robert J⋅Schneider, Bryan P⋅Smith, Mary L⋅Wagner, Lynne I⋅Fetting, John H⋅Davidson, Nancy E⋅Goldstein, Lori J⋅Miller, Kathy D and Sparano, Joseph A
Cancer, vol. 119, (no. 6), pp. 1140-8, 2013/Mar/15. | Journal Article
 
Synthesis of 2,6-difluoro-N-(3-[11C]methoxy-1H-pyrazolo[3,4-b]pyridine-5-yl)-3- ( propylsulfonamidio)benzamide as a new potential PET agent for imaging of B-RafV600E in cancers
Wang, Min⋅Gao, Mingzhang⋅Miller, Kathy D and Zheng, Qi-Huang
Bioorganic and Medicinal Chemistry Letters, vol. 23, (no. 4), pp. 1017-1021, 2013. | Journal Article
 
Synthesis of 2,6-difluoro-N-(3-[11C]methoxy-1H-pyrazolo[3,4-b]pyridine-5-yl)-3-(propylsulfonamidio)benzamide as a new potential PET agent for imaging of B-Raf(V600E) in cancers.
Wang, Min⋅Wang, Min⋅Gao, Mingzhang⋅Gao, Mingzhang⋅Miller, Kathy D⋅Miller, Kathy D⋅Zheng, Qi-Huang and Zheng, Qi Huang
Bioorganic & medicinal chemistry letters, vol. 23, (no. 4), pp. 1017-21, 2013/Feb/15. | Journal Article
 
Synthesis of radiolabeled protein disulfide isomerase (PDI) inhibitors as new potential PET agents for imaging of the enzyme PDI in neurological disorders and cancer.
Gao, Mingzhang⋅Yang, Qingqing⋅Wang, Min⋅Miller, Kathy D⋅Sledge, George W and Zheng, Qi Huang
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, vol. 74, pp. 61-9, 2013/Apr. | Journal Article
 
Synthesis of (Z)-2-((1H-indazol-3-yl)methylene)-6-[¹¹C]methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one as a new potential PET probe for imaging of the enzyme PIM1.
Gao, Mingzhang⋅Wang, Min⋅Miller, Kathy D and Zheng, Qi Huang
Bioorganic & medicinal chemistry letters, vol. 23, (no. 15), pp. 4342-6, 2013/Aug/1. | Journal Article
2012
[11C]GSK2126458 and [18F]GSK2126458, the first radiosynthesis of new potential PET agents for imaging of PI3K and mTOR in cancers
Wang, Min⋅Gao, Mingzhang⋅Miller, Kathy D⋅Sledge, George W and Zheng, Qi Huang
Bioorganic and Medicinal Chemistry Letters, vol. 22, (no. 4), pp. 1569-1574, 2012. | Journal Article
 
A brief intervention to minimize psychosexual morbidity in dyads coping with breast cancer.
Decker, Carol L⋅Pais, Shobha⋅Miller, Kathy D⋅Goulet, Robert and Fifea, Betsy L
Oncology nursing forum, vol. 39, (no. 2), pp. 176-85, 2012/Mar. | Journal Article
 
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors.
Jhaveri, Komal⋅Miller, Kathy⋅Rosen, Lee⋅Schneider, Bryan⋅Chap, Linnea⋅Hannah, Alison⋅Zhong, Ziyang⋅Ma, Weining⋅Hudis, Clifford and Modi, Shanu
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 18), pp. 5090-5098, September 15, 2012. | Journal Article
 
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.
Miller, Kathy D⋅O'Neill, A⋅Perez, E A⋅Seidman, A D and Sledge, G W
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 23, (no. 2), pp. 331-7, 2012/Feb. | Journal Article
 
A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine.
Krop, Ian E⋅Lorusso, Patricia⋅Miller, Kathy D⋅Modi, Shanu⋅Yardley, Denise⋅Rodriguez, Gladys⋅Guardino, Ellie⋅Lu, Michael⋅Zheng, Maoxia⋅Girish, Sandhya⋅Amler, Lukas⋅Winer, Eric P and Rugo, Hope S
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 26), pp. 3234-41, 2012/Sep/10. | Journal Article
 
Cognitive appraisals, coping and depressive symptoms in breast cancer patients.
Bigatti, Silvia M⋅Steiner, Jennifer L and Miller, Kathy D
Stress and health : journal of the International Society for the Investigation of Stress, vol. 28, (no. 5), pp. 355-61, 2012/Dec. | Journal Article
 
Health-Related Quality of Life of African American Breast Cancer Survivors Compared With Healthy African American Women
Von Ah, Diane⋅Russell, Kathleen M⋅Carpenter, Janet S⋅Monahan, Patrick O⋅Qianqian, Zhao⋅Tallman, Eileen⋅Ziner, Kim W⋅Storniolo, Anna M⋅Miller, Kathy D⋅Giesler, Raymond B⋅Haase, Joan E⋅Otte, Julie and Champion, Victoria L
Cancer Nursing, vol. 35, (no. 5), Sep/Oct 2012. | Journal Article
 
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.
Schneider, Bryan P⋅Shen, Fei and Miller, Kathy D
The lancet oncology, vol. 13, (no. 10), pp. e427-36, 2012/Oct. | Journal Article
 
Predicting fear of breast cancer recurrence and self-efficacy in survivors by age at diagnosis.
Ziner, Kim W⋅Sledge, George W⋅Bell, Cynthia J⋅Johns, Shelley⋅Miller, Kathy D and Champion, Victoria L
Oncology nursing forum, vol. 39, (no. 3), pp. 287-95, 2012/May/1. | Journal Article
 
Simple synthesis of carbon-11-labeled chromen-4-one derivatives as new potential PET agents for imaging of DNA-dependent protein kinase (DNA-PK) in cancer.
Gao, Mingzhang⋅Wang, Min⋅Miller, Kathy D and Zheng, Qi Huang
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, vol. 70, (no. 8), pp. 1558-63, 2012/Aug. | Journal Article
 
Synthesis of 2-[11C]methoxy-3,17β-O,O-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers.
Wang, Min⋅Xu, Lu⋅Gao, Mingzhang⋅Miller, Kathy D⋅Sledge, George W and Zheng, Qi Huang
Steroids, vol. 77, (no. 8-9), pp. 864-70, 2012/Jul. | Journal Article
2011
[11C]enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C.
Wang, Min⋅Xu, Lu⋅Gao, Mingzhang⋅Miller, Kathy D⋅Sledge, George W and Zheng, Qi Huang
Bioorganic & medicinal chemistry letters, vol. 21, (no. 6), pp. 1649-53, 2011/Mar/15. | Journal Article